Citius Oncology, Inc. (CTOR)
1.22
+0.04
(+3.39%)
USD |
NASDAQ |
Feb 13, 16:00
1.19
-0.03
(-2.46%)
After-Hours: 20:00
Citius Oncology Shareholders Equity (Quarterly) : 58.41M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | 79.96M |
| Amgen, Inc. | 8.658B |
| Amicus Therapeutics, Inc. | 230.42M |
| Soligenix, Inc. | 7.598M |
| Tonix Pharmaceuticals Holding Corp. | 231.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.97M |
| Total Liabilities (Quarterly) | 51.56M |
| Debt to Equity Ratio | 0.0651 |
| Current Ratio | 0.8308 |
| Net Debt Paydown Yield | -0.90% |